Correlation Between Accenture Plc and Diamyd Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Accenture Plc and Diamyd Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accenture Plc and Diamyd Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accenture plc and Diamyd Medical AB, you can compare the effects of market volatilities on Accenture Plc and Diamyd Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accenture Plc with a short position of Diamyd Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accenture Plc and Diamyd Medical.

Diversification Opportunities for Accenture Plc and Diamyd Medical

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Accenture and Diamyd is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Accenture plc and Diamyd Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diamyd Medical AB and Accenture Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accenture plc are associated (or correlated) with Diamyd Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diamyd Medical AB has no effect on the direction of Accenture Plc i.e., Accenture Plc and Diamyd Medical go up and down completely randomly.

Pair Corralation between Accenture Plc and Diamyd Medical

Assuming the 90 days horizon Accenture plc is expected to generate 0.55 times more return on investment than Diamyd Medical. However, Accenture plc is 1.81 times less risky than Diamyd Medical. It trades about 0.09 of its potential returns per unit of risk. Diamyd Medical AB is currently generating about -0.11 per unit of risk. If you would invest  33,305  in Accenture plc on August 29, 2024 and sell it today you would earn a total of  1,215  from holding Accenture plc or generate 3.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Accenture plc  vs.  Diamyd Medical AB

 Performance 
       Timeline  
Accenture plc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Accenture plc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Accenture Plc may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Diamyd Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diamyd Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Accenture Plc and Diamyd Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Accenture Plc and Diamyd Medical

The main advantage of trading using opposite Accenture Plc and Diamyd Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accenture Plc position performs unexpectedly, Diamyd Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diamyd Medical will offset losses from the drop in Diamyd Medical's long position.
The idea behind Accenture plc and Diamyd Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios